7th November 2019
Researchers from the Centre for Cancer Prevention have developed a non-invasive test to detect cervical pre-cancer by analysing urine and vaginal samples women collect themselves.
Read more3rd October 2019
A lifetime model evaluating the financial, health and social impact of multigene testing at diagnosis for all breast cancer patients was found to save lives and be extremely cost-effective for both UK and US health systems.
Read more30th September 2019
Results of an interim analysis from the KEYNOTE-522 trial have shown a treatment combination of immunotherapy plus chemotherapy to improve response rates in patients with early triple-negative breast cancer. Prof Peter Schmid presented the results at the ESMO Congress 2019 in Barcelona, Spain.
Read more25th September 2019
A urine test that can detect early stage pancreatic cancer has reached the final stage of validation before being developed for use with patients. If successful, this non-invasive urine test would be the first in the world to help clinicians detect the highly lethal cancer at an early stage – enabling many more people to have surgery to remove their tumour, which is currently the only potentially curative treatment.
Read more17th September 2019
A new and simple blood test has been found to efficiently and accurately detect the presence of aggressive prostate cancer, in a study led by BCI’s Professor Yong-Jie Lu.
Read more13th September 2019
Researchers are calling for population-wide BRCA testing in the Jewish community after finding it to be more effective than current approaches, cost effective and to have a high satisfaction rate with those undergoing testing.
Read more